| ISPC 0.1365 17.17% | CTNT 0.0953 -40.73% | BYND 0.8226 5.19% | YXT 0.496 34.05% | TZA 5.08 -6.45% | EFOI 6.49 210.53% | TSLL 13.9 6.35% | NVDA 201.68 1.68% | BITO 10.63 2.71% | NFLX 97.31 -9.72% | INTC 68.5 0.00% | ZSPC 0.0536 -38.46% | TQQQ 58.59 3.83% | SOXS 18.87 -6.95% | TSLA 400.62 3.01% | XLE 55.02 -2.76% | AMC 1.86 15.53% | SCO 8.47 9.72% | PLUG 2.78 -2.80% | BMNG 1.6 4.58% | IBIT 43.94 2.83% | AAL 12.78 4.16% | BZAI 2.52 45.66% | CRML 12.56 35.49% | SOFI 19.43 2.10% | HIVE 2.51 14.87% | GRAB 4.21 4.73% | SPY 710.14 1.21% | SQQQ 56.39 -3.79% | SOXL 94.68 7.14% | SMR 12.65 10.87% | BMNR 22.95 2.27% | SNAP 6.03 0.17% | UCAR 1.49 29.57% | HIMS 28.82 6.78% | LZMH 0.1736 -84.07% | HYG 80.65 0.37% | DRIP 5.25 9.83% | ONDS 10 -1.96% | DVLT 0.758 -9.49% | AAPL 270.23 2.59% | QQQ 648.85 1.31% | MARA 11.6 0.43% | MSTR 166.52 11.80% | AMZN 250.56 0.34% | PLTR 146.39 2.54% | SPDN 9.13 -1.19% | PBM 7.6 29.47% | IONQ 46.09 3.16% | MSFT 422.79 0.60%

Leidos Holdings, Inc. (NYSE:LDOS) Financial Overview and Analyst Ratings

Leidos Holdings, Inc. (NYSE:LDOS) is a key player in the technology and defense sectors, providing digital and mission solutions to both government and commercial clients. The company is set to announce its financial results for the fourth quarter and full year of 2025 on February 17, 2026.

Citigroup recently maintained its "Buy" rating for Leidos, with the stock priced at $195.60 as of January 13, 2026. Citigroup also raised its price target from $218 to $232, indicating confidence in Leidos' future performance. This suggests that Citigroup sees potential for the stock to increase in value, reflecting a positive outlook on the company's financial health and market position.

On January 7, 2026, Stifel Nicolaus analyst Jonathan Siegmann set a price target of $220 for Leidos, with the stock trading at $196.61 at the time. This target represents an approximate 11.9% increase from the current price. However, Stifel downgraded Leidos from "Buy" to "Hold," as reported by TheFly, indicating a more cautious stance on the stock's short-term potential.

Leidos' financial metrics provide further insight into its market valuation. The company has a price-to-earnings (P/E) ratio of approximately 17.21, suggesting a moderate valuation of its earnings. The price-to-sales ratio is about 1.39, indicating how much investors are willing to pay per dollar of sales. Additionally, the enterprise value to sales ratio stands at around 1.64, reflecting the company's total valuation relative to its sales.

Leidos' financial leverage is highlighted by its debt-to-equity ratio of approximately 1.07, indicating a balanced approach to financing through debt and equity. The current ratio of around 1.62 suggests that Leidos is well-positioned to cover its short-term liabilities with its short-term assets. These metrics, combined with an earnings yield of about 5.81%, provide a comprehensive view of Leidos' financial health and investment potential.

Published on: January 14, 2026